abstract |
Use of a composition comprising: (a) at least one antigen; (b) a glycolipid adjuvant selected from the group consisting of 3-des-O-acylated monophosphoryl lipid A (3-DMPL) or a salt thereof; and (c) a diluent, excipient, or vehicle that can be administered sublingually, in the preparation of a medicament for the treatment or prevention of a bacterial infection, viral infection, cancer, autoimmunity, or allergy, in which the medicament is administered sublingually. |